{"version":"1.0","provider_name":"GRAIL","provider_url":"https:\/\/grail.com","author_name":"Meredith Hemler","author_url":"https:\/\/grail.com\/stories\/author\/mhemler\/","title":"GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care - GRAIL","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"eYYeFu6kyT\"><a href=\"https:\/\/grail.com\/press-releases\/grail-initiates-first-interventional-study-using-its-multi-cancer-early-detection-test-to-guide-clinical-care\/\">GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/grail.com\/press-releases\/grail-initiates-first-interventional-study-using-its-multi-cancer-early-detection-test-to-guide-clinical-care\/embed\/#?secret=eYYeFu6kyT\" width=\"600\" height=\"338\" title=\"&#8220;GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care&#8221; &#8212; GRAIL\" data-secret=\"eYYeFu6kyT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"http:\/\/grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26@2x.jpg","thumbnail_width":460,"thumbnail_height":260,"description":"\u2013The PATHFINDER Study will Return GRAIL\u2019s Test Results to Providers for the First Time \u2014 \u2014 First Participants Successfully Enrolled \u2014 \u2014 FDA Approves IDE for GRAIL\u2019s Test \u2014 MENLO PARK, Calif., February 18, 2020 \u2013 GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced [&hellip;]"}